Top Markets
Coin of the day
Nymox Pharmaceutical Corporation Nymox Pharmaceutical Corporation

Nymox Pharmaceutical Corporation

NYMX
Clasificación en acciones #23483
Nymox Pharmaceutical Corporation operates as a biopharmaceutical firm,... Nymox Pharmaceutical Corporation operates as a biopharmaceutical firm, primarily focused on the discovery and advancement of medications for the aging population across Canada, the United States, Europe, and other international regions. The company's leading experimental compound is Fexapotide Triflutate (NX-1207), which has successfully concluded Phase III clinical trials for benign prostatic hyperplasia treatment. It has also completed Phase II trials for localized low-grade prostate cancer and is currently in preclinical studies for hepatocellular carcinoma. In addition to its drug pipeline, Nymox develops and markets diagnostic products. These include NicAlert and TobacAlert, tests that utilize urine or saliva samples to identify the use of tobacco products. The company further offers AlzheimAlert, a proprietary urine-based assay designed to aid healthcare professionals in diagnosing Alzheimer's disease. Alongside this diagnostic tool, Nymox is actively researching and developing therapeutic treatments for Alzheimer's disease. Founded in 1989, the company is headquartered in Nassau, the Bahamas.
Precio por acción
$0.977
Última sincronización: 2023-08-11
Capitalización bursátil
$72.98M
Cambio (1 día)
4.94%
Cambio (1 año)
0.00%
País
BS
Comercio Nymox Pharmaceutical Corporation (NYMX)

Categoría

Historial del precio de la acción de Nymox Pharmaceutical Corporation (NYMX)
Precio más alto de cierre: $0.99 el 2023-08-01

Precio más bajo de cierre: $6.33 el 1997-11-01
Historial del precio de la acción de Nymox Pharmaceutical Corporation desde 1997 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2023 151.39%
2022 -66.65%
2021 -48.99%
2020 9.87%
2019 34.83%
2018 -54.85%
2017 16.78%
2016 -15.16%
2015 708.48%
2014 -93.14%
2013 -9.25%
2012 -13.68%
2011 50.92%
2010 17.92%
2009 47.20%
2008 -48.95%
2007 74.88%
2006 62.86%
2005 -26.81%
2004 -2.76%
2003 -25.35%
2002 1.15%
2001 147.59%
2000 -46.71%
1999 -43.98%
1998 -24.06%
1997 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH